Syros Pharmaceuticals Inc expected to post a loss of 47  cents a share - Earnings Preview

Syros Pharmaceuticals

02/05/2022 19:34

* Syros Pharmaceuticals Inc  SYRS.OQ   SYRS.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 4
(estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 2.0% increase in revenue to $4.924 million from $4.83 million
a year ago, according to the mean estimate from 8 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Syros
Pharmaceuticals Inc
is for a loss of 47 cents per share. For the same quarter last
year, the company reported a loss of 23 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Syros
Pharmaceuticals Inc is $15​, above​ its last closing price
of $0.84. ​​​

This summary was machine generated May 2 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated